Impact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosa

The macrolide antibiotic, azithromycin (AZM), has been reported to improve the clinical outcome of cystic fibrosis patients, many of whom are chronically-infected with Pseudomonas aeruginosa. However, the highest clinically-achievable concentrations of this drug are well-below the minimum inhibitory...

Descripción completa

Detalles Bibliográficos
Autores principales: Swatton, J. E., Davenport, P. W., Maunders, E. A., Griffin, J. L., Lilley, K. S., Welch, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726577/
https://www.ncbi.nlm.nih.gov/pubmed/26808156
http://dx.doi.org/10.1371/journal.pone.0147698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726577/
https://www.ncbi.nlm.nih.gov/pubmed/26808156
http://dx.doi.org/10.1371/journal.pone.0147698

Ejemplares similares